logo

For the Inventor, By the Inventor

Darmstadt, Germany

Franz-Werner Kluxen

This inventor holds 11 USPTO granted patents and 1 EPO patent. Top assignees: Merck Patent Gesellschaft MIT Beschraenkter Haftung, Merck Patent Gesellschaft MIT Beschrankter Haftung, Merck Patent Gesellschaft MIT Beschränkter Haftung. Active years: 2000-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Franz-Werner Kluxen. Retrieved from https://idiyas.com/inventor/franz-werner-kluxen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 63.6


Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 101(Granted Patents)


Company Filing History:

goldMedal5 out of 100 
 
Merck Patent Gesellschaft MIT Beschraenkter Haftung
 patents
silverMedal5 out of 1,248 
 
Merck Patent Gesellschaft MIT Beschrankter Haftung
 patents
bronzeMedal1 out of 37 
 
Merck Patent Gesellschaft MIT Beschränkter Haftung
 patents

Years Active: 2000-2004

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 6787548 - Thienopyrimidines as phosphodiesterase inhibitors (2004-09-07),
2. 6495557 - Condensed thienopyrimidines with phosphodiesterase-v inhibiting action (2002-12-17),
3. 6495554 - Thienopyrimidines (2002-12-17),
4. 6479494 - Arylalkanoyl pyridazines (2002-11-12),
5. 6420368 - Thienopyrimidines (2002-07-16),
6. 6417188 - Arylalkanoylpyridazines (2002-07-09),
7. 6376493 - Benzoylpyridazines (2002-04-23),
8. 6143777 - Aminothiophene carboxylic acid amides and the use thereof as (2000-11-07),
9. 6130223 - Thienopyrimidine with phosphodiesterase V inhibiting effect (2000-10-10),
10. 6110920 - Thienopyrimidines (2000-08-29),
11. 6107295 - Arylalkanoyl pyridazines (2000-08-22),

Title: Franz-Werner Kluxen: Innovator in Pharmaceutical Chemistry

Introduction

Franz-Werner Kluxen is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways. With a total of 11 patents to his name, Kluxen's work has had a considerable impact on medical treatments.

Latest Patents

One of Kluxen's latest patents involves thienopyrimidines as phosphodiesterase inhibitors. These thienopyrimidines, along with their physiologically compatible salts, exhibit phosphodiesterase V inhibiting activity. This innovation holds promise for treating diseases of the cardiovascular system and offers potential therapies for erectile dysfunction.

Career Highlights

Throughout his career, Kluxen has worked with prominent organizations, including Merck Patent Gesellschaft mit beschränkter Haftung. His expertise in pharmaceutical development has positioned him as a key figure in the industry, contributing to advancements in drug formulation and therapeutic applications.

Collaborations

Kluxen has collaborated with esteemed colleagues such as Rochus Jonas and Pierre Schelling. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.

Conclusion

Franz-Werner Kluxen's contributions to pharmaceutical chemistry and his innovative patents underscore his importance in the field. His work continues to influence the development of new treatments, showcasing the vital role of inventors in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…